A Study to Assess Nomlabofusp in Adolescents and Children With Friedreich's Ataxia
Clinical trial NCT06681766 · TERMINATED
Trial details
- NCT number
- NCT06681766
- Sponsor
- Larimar Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-06
- Primary completion
- 2025-04-27
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.